Frank Rimerman Advisors’s GSK GSK Stock Holding History

Frank Rimerman Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$843K	Sell	15,272 -138	-0.9%	-$7.48K	0.06%	272
2025 Q4	$756K	Buy	15,410 +1,866	+14%	+$87K	0.05%	293
2025 Q3	$585K	Buy	13,544 +6,083	+82%	+$238K	0.04%	333
2025 Q2	$287K	Buy	+7,461	New	+$285K	0.02%	467
2024 Q3	–	Sell	-21,359	Closed	-$822K	–	541
2024 Q2	$822K	Buy	+21,359	New	+$898K	0.06%	248

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Frank Rimerman Advisors's GSK Position: Q1 2026 in Review

Frank Rimerman Advisors reduced its GSK (GSK) stake by 0.9% in Q1 2026, selling an estimated $7.48K and leaving 15,272 shares worth $843K. The position accounts for 0.06% of the portfolio, ranked #272.

Frank Rimerman Advisors first reported a position in GSK in Q2 2024 and has held it in 5 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Frank Rimerman Advisors held 15,272 shares of GSK worth $843K as of Q1 2026.
Frank Rimerman Advisors sold 138 GSK shares in Q1 2026, an estimated $7.48K.
GSK made up 0.06% of Frank Rimerman Advisors's portfolio in Q1 2026, its #272 holding.
Frank Rimerman Advisors first reported a position in GSK in Q2 2024 and has held it in 5 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.